|
US3051621A
(en)
*
|
1959-10-22 |
1962-08-28 |
Grove Lab Inc |
Gel composition, pressurized container with same, and method of preparation
|
|
US3050443A
(en)
*
|
1960-02-16 |
1962-08-21 |
James F Schuyler |
Headache remedy containing ammonia
|
|
NL262354A
(en:Method)
*
|
1960-03-17 |
|
|
|
|
US3039928A
(en)
*
|
1960-03-17 |
1962-06-19 |
Abbott Lab |
Stable aqueous isoproteronol compositions
|
|
US3088874A
(en)
*
|
1960-05-23 |
1963-05-07 |
Union Carbide Corp |
Powder aerosol
|
|
US3282781A
(en)
*
|
1960-11-25 |
1966-11-01 |
Merck & Co Inc |
Inhalant compositions
|
|
BE632504A
(en:Method)
*
|
1962-05-24 |
|
|
|
|
US3169095A
(en)
*
|
1962-10-30 |
1965-02-09 |
Rexall Drug Chemical |
Self-propelling powder-dispensing compositions
|
|
NL302251A
(en:Method)
*
|
1963-01-28 |
1965-10-11 |
|
|
|
US3710782A
(en)
*
|
1969-10-01 |
1973-01-16 |
Hauser Res And Eng Co |
Method of treating human skin with a composition for electromedical applications
|
|
IL51314A
(en)
*
|
1976-01-30 |
1980-03-31 |
Fisons Ltd |
Disodium cromoglycate of low moisture content and pharmaceutical compositions containing it
|
|
AU522792B2
(en)
*
|
1977-07-19 |
1982-06-24 |
Fisons Plc |
Pressure pack formulation
|
|
US4352789A
(en)
*
|
1980-03-17 |
1982-10-05 |
Minnesota Mining And Manufacturing Company |
Aerosol compositions containing finely divided solid materials
|
|
US4655231A
(en)
*
|
1984-01-09 |
1987-04-07 |
Advanced Tobacco Products, Inc. |
Snuff and preparation thereof
|
|
US4576949A
(en)
*
|
1984-05-07 |
1986-03-18 |
The Upjohn Company |
Use of 5,6,7,8-tetrahydroquinolines and 5,6-dihydropyrindines as leukotriene and lipoxygenase inhibitors and the novel 3-substituted compounds therein
|
|
EP0213108A3
(de)
*
|
1985-06-26 |
1987-07-15 |
Kurt Dr. Burghart |
Pharmazeutische Zubereitung mit einem Antihypotonikum als wirksames Mittel
|
|
JPH0645538B2
(ja)
*
|
1987-09-30 |
1994-06-15 |
日本化薬株式会社 |
ニトログリセリンスプレー剤
|
|
FR2625677A1
(fr)
*
|
1988-01-07 |
1989-07-13 |
Cosnier Alain |
Composition medicamenteuse destinee a etre administree sous forme d'aerosol
|
|
GB2216794B
(en)
*
|
1988-03-22 |
1991-11-20 |
Fisons Plc |
Pharmaceuticals compositions
|
|
US5225183A
(en)
*
|
1988-12-06 |
1993-07-06 |
Riker Laboratories, Inc. |
Medicinal aerosol formulations
|
|
US5766573A
(en)
*
|
1988-12-06 |
1998-06-16 |
Riker Laboratories, Inc. |
Medicinal aerosol formulations
|
|
US5439670A
(en)
*
|
1989-11-28 |
1995-08-08 |
Riker Laboratories, Inc. |
Medicinal aerosol formulations
|
|
DE4003270A1
(de)
*
|
1990-02-03 |
1991-08-08 |
Boehringer Ingelheim Kg |
Neue treibgase und ihre verwendung in arzneimittelzubereitungen
|
|
US5118494A
(en)
*
|
1990-03-23 |
1992-06-02 |
Minnesota Mining And Manufacturing Company |
Use of soluble fluorosurfactants for the preparation of metered-dose aerosol formulations
|
|
US5175152A
(en)
*
|
1990-09-28 |
1992-12-29 |
Singh Nikhilesh N |
Composition containing ephedrine base and alkyl salicylate for the delivery of ephedrine base in vapor form
|
|
MX9203481A
(es)
|
1990-10-18 |
1992-07-01 |
Minnesota Mining & Mfg |
Formulaciones.
|
|
US5919435A
(en)
*
|
1990-11-09 |
1999-07-06 |
Glaxo Group Limited |
Aerosol formulation containing a particulate medicament
|
|
US5785952A
(en)
*
|
1990-11-09 |
1998-07-28 |
Glaxo Group Limited |
Aerosol medicament formulation having a surface coating of surfactant
|
|
NZ243062A
(en)
|
1991-06-10 |
1993-09-27 |
Schering Corp |
Aerosol containing medicament and 1,1,1,2-tetrafluoroethane
|
|
US5234933A
(en)
*
|
1991-10-31 |
1993-08-10 |
Board Of Governors Of Wayne State University And Vanderbilt University |
Cyclic hydroxamic acids
|
|
ATE128350T1
(de)
*
|
1991-12-12 |
1995-10-15 |
Glaxo Group Ltd |
Pharmazeutische aerosolformulierung.
|
|
US5653962A
(en)
*
|
1991-12-12 |
1997-08-05 |
Glaxo Group Limited |
Aerosol formulations containing P134a and particulate medicaments
|
|
CA2125666C
(en)
*
|
1991-12-12 |
2002-07-16 |
Rachel Ann Akehurst |
Medicaments
|
|
US5658549A
(en)
*
|
1991-12-12 |
1997-08-19 |
Glaxo Group Limited |
Aerosol formulations containing propellant 134a and fluticasone propionate
|
|
IL104068A
(en)
*
|
1991-12-12 |
1998-10-30 |
Glaxo Group Ltd |
Pharmaceutical preparations in a spray without surfactant containing 1, 1, 1, 2 tetrafluoroethane or 1,1,2,3,3 petafluor N propane as propellant
|
|
US5744123A
(en)
*
|
1991-12-12 |
1998-04-28 |
Glaxo Group Limited |
Aerosol formulations containing P134a and particulate medicaments
|
|
US5674471A
(en)
*
|
1991-12-12 |
1997-10-07 |
Glaxo Group Limited |
Aerosol formulations containing P134a and salbutamol
|
|
US5916540A
(en)
|
1994-10-24 |
1999-06-29 |
Glaxo Group Limited |
Aerosol formulations containing P134A and/or P227 and particulate medicament
|
|
US5736124A
(en)
*
|
1991-12-12 |
1998-04-07 |
Glaxo Group Limited |
Aerosol formulations containing P134a and particulate medicament
|
|
US7101534B1
(en)
|
1991-12-18 |
2006-09-05 |
3M Innovative Properties Company |
Suspension aerosol formulations
|
|
CA2126244C
(en)
|
1991-12-18 |
2000-09-26 |
Robert K. Schultz |
Suspension aerosol formulations
|
|
US7105152B1
(en)
|
1991-12-18 |
2006-09-12 |
3M Innovative Properties Company |
Suspension aerosol formulations
|
|
RO117414B1
(ro)
*
|
1992-12-09 |
2002-03-29 |
Jager Paul D Waterbury |
Compozitie farmaceutica de aerosol in solutie
|
|
ATE163006T1
(de)
*
|
1993-06-01 |
1998-02-15 |
Ono Pharmaceutical Co |
Pentansäurederivate
|
|
EP0640609A1
(en)
*
|
1993-08-24 |
1995-03-01 |
Ono Pharmaceutical Co., Ltd. |
Fused phenol derivatives having inhibitory activity on TXA2 synthetase, and 5-lipoxygenase and scavenging activity on oxygen species
|
|
CA2137106C
(en)
*
|
1993-12-03 |
2000-02-08 |
Hisao Nakai |
Amidinophenol derivatives
|
|
ES2145254T3
(es)
*
|
1993-12-20 |
2000-07-01 |
Minnesota Mining & Mfg |
Formulaciones de aerosoles que contienen flunisolida.
|
|
KR100226619B1
(ko)
|
1994-09-20 |
1999-10-15 |
우에노 토시오 |
아미디노페놀 유도체
|
|
US5840213A
(en)
*
|
1995-04-28 |
1998-11-24 |
Great Lakes Chemical Corporation |
Uses of heptafluoropropane
|
|
US5679287A
(en)
*
|
1995-04-28 |
1997-10-21 |
Great Lakes Chemical Corporation |
Uses of heptafluoropropane
|
|
KR980009238A
(ko)
|
1995-07-28 |
1998-04-30 |
우에노 도시오 |
설포닐아미노산 유도체
|
|
ATE226936T1
(de)
*
|
1995-08-08 |
2002-11-15 |
Ono Pharmaceutical Co |
Hydroxamsäurederivate verwendbar zur hemmung von gelatinase
|
|
AUPN814496A0
(en)
*
|
1996-02-19 |
1996-03-14 |
Monash University |
Dermal penetration enhancer
|
|
US5861268A
(en)
*
|
1996-05-23 |
1999-01-19 |
Biomide Investment Limited Partnership |
Method for induction of tumor cell apoptosis with chemical inhibitors targeted to 12-lipoxygenase
|
|
US6054488A
(en)
*
|
1996-06-11 |
2000-04-25 |
3M Innovative Properties Company |
Medicinal aerosol formulations of formoterol
|
|
GB9616237D0
(en)
|
1996-08-01 |
1996-09-11 |
Norton Healthcare Ltd |
Aerosol formulations
|
|
JP2001511160A
(ja)
|
1997-02-05 |
2001-08-07 |
ヤゴ リサーチ アクチェンゲゼルシャフト |
医学用エアゾール配合物
|
|
US5891420A
(en)
*
|
1997-04-21 |
1999-04-06 |
Aeropharm Technology Limited |
Environmentally safe triancinolone acetonide aerosol formulations for oral inhalation
|
|
US5891419A
(en)
*
|
1997-04-21 |
1999-04-06 |
Aeropharm Technology Limited |
Environmentally safe flunisolide aerosol formulations for oral inhalation
|
|
US6129905A
(en)
*
|
1997-04-21 |
2000-10-10 |
Aeropharm Technology, Inc. |
Aerosol formulations containing a sugar as a dispersant
|
|
US7153866B1
(en)
*
|
1997-05-27 |
2006-12-26 |
The United States Of America As Represented By The Department Of Health And Human Services |
Use of tempol for the treatment of Li-Fraumeni syndrome and ataxia telangiectasia
|
|
US20010031244A1
(en)
*
|
1997-06-13 |
2001-10-18 |
Chiesi Farmaceutici S.P.A. |
Pharmaceutical aerosol composition
|
|
JPH11187882A
(ja)
|
1997-12-26 |
1999-07-13 |
Ono Pharmaceut Co Ltd |
新規なポリペプチド、その製造方法、そのポリペプチドをコードするcDNA、そのcDNAからなるベクター、そのベクターで形質転換された宿主細胞、そのポリペプチドの抗体、およびそのペプチドまたは抗体を含有する薬学的組成物
|
|
ES2234266T3
(es)
|
1998-07-24 |
2005-06-16 |
Jago Research Ag |
Formulaciones medicas para aerosoles.
|
|
DK1102579T3
(da)
|
1998-08-04 |
2003-07-14 |
Jago Res Ag |
Medicinske aerosolformuleringer
|
|
US6458338B1
(en)
|
1998-09-22 |
2002-10-01 |
Aeropharm Technology Incorporated |
Amino acid stabilized medicinal aerosol formulations
|
|
US6136294C1
(en)
*
|
1998-09-22 |
2002-09-24 |
Aeropharm Technology Inc |
Amino acid stabilized medical aerosol formulation
|
|
DZ2947A1
(fr)
*
|
1998-11-25 |
2004-03-15 |
Chiesi Farma Spa |
Inhalateur à compteur de dose sous pression.
|
|
US6315985B1
(en)
*
|
1999-06-18 |
2001-11-13 |
3M Innovative Properties Company |
C-17/21 OH 20-ketosteroid solution aerosol products with enhanced chemical stability
|
|
GB0208742D0
(en)
|
2002-04-17 |
2002-05-29 |
Bradford Particle Design Ltd |
Particulate materials
|
|
PT1417975E
(pt)
|
2001-07-23 |
2011-05-30 |
Ono Pharmaceutical Co |
Medicamentos que cont?m um agonista de ep4 como princ?pio activo destinados a doen?as associadas a perda de massa ?ssea
|
|
JP3843454B2
(ja)
|
2002-02-19 |
2006-11-08 |
小野薬品工業株式会社 |
縮合ピリダジン誘導体化合物およびその化合物を有効成分として含有する薬剤
|
|
US7582284B2
(en)
*
|
2002-04-17 |
2009-09-01 |
Nektar Therapeutics |
Particulate materials
|
|
EP2266533A3
(en)
*
|
2002-06-25 |
2011-12-14 |
Acrux DDS Pty Ltd |
Transdermal delivery rate control using amorphous pharmaceutical compositions
|
|
US20050181032A1
(en)
*
|
2002-06-25 |
2005-08-18 |
Acrux Dds Pty Ltd. |
Metastable pharmaceutical compositions
|
|
US20050186141A1
(en)
*
|
2002-06-25 |
2005-08-25 |
Acrux Dds Pty Ltd. |
Transdermal aerosol compositions
|
|
EP1522314B1
(en)
|
2002-06-26 |
2014-03-05 |
Ono Pharmaceutical Co., Ltd. |
Remedies for diseases caused by vascular contraction or dilation
|
|
DK2206517T3
(da)
|
2002-07-03 |
2023-11-06 |
Ono Pharmaceutical Co |
Immunpotentierende sammensætninger omfattende af anti-PD-L1-antistoffer
|
|
AU2003241836A1
(en)
|
2002-10-03 |
2004-04-23 |
Ono Pharmaceutical Co., Ltd. |
Lpa receptor antagonists
|
|
JPWO2004032964A1
(ja)
*
|
2002-10-10 |
2006-02-09 |
国立大学法人京都大学 |
アレルギー性疾患治療剤
|
|
PT2465537T
(pt)
|
2002-10-10 |
2016-08-03 |
Ono Pharmaceutical Co |
Microsferas compreendendo ono-1301
|
|
US7563869B2
(en)
|
2003-01-23 |
2009-07-21 |
Ono Pharmaceutical Co., Ltd. |
Substance specific to human PD-1
|
|
TWI344955B
(en)
|
2003-03-14 |
2011-07-11 |
Ono Pharmaceutical Co |
Heterocyclic rinf having nitrogen atom derivatives and medicament containing the derivatives as active ingredient
|
|
EP1619193A4
(en)
|
2003-04-18 |
2010-08-11 |
Ono Pharmaceutical Co |
SPIROPIPERIDINE COMPOUND AND MEDICINAL USE THEREOF
|
|
AU2004240629B2
(en)
*
|
2003-05-16 |
2010-02-25 |
Arriva Pharmaceuticals, Inc. |
Treatment of respiratory disease by inhalation of synthetic matrix metalloprotease inhibitors
|
|
WO2006031210A1
(en)
|
2003-05-29 |
2006-03-23 |
Board Of Regents, The University Of Texas Systems |
Jabi as a prognostic marker and a therapeutic target for human cancer
|
|
JP4666257B2
(ja)
|
2003-07-25 |
2011-04-06 |
小野薬品工業株式会社 |
軟骨関連疾患治療剤
|
|
ES2754221T3
(es)
|
2003-08-29 |
2020-04-16 |
Ono Pharmaceutical Co |
Compuesto capaz de unirse al receptor de S1P y uso farmacéutico del mismo
|
|
MXPA06002152A
(es)
|
2003-09-01 |
2006-05-22 |
Ono Pharmaceutical Co |
Compuesto de anillo condensado y uso del mismo.
|
|
AU2004272077A1
(en)
*
|
2003-09-10 |
2005-03-24 |
Map Pharmaceuticals, Inc. |
Aerosol formulations for delivery of dihydroergotamine to the systemic circulation via pulmonary inhalation
|
|
BRPI0415707A
(pt)
*
|
2003-10-20 |
2006-12-19 |
Schering Corp |
composições farmacêuticas
|
|
WO2005063704A1
(ja)
|
2003-12-25 |
2005-07-14 |
Ono Pharmaceutical Co., Ltd. |
アゼチジン環化合物およびその医薬
|
|
US20060018840A1
(en)
*
|
2004-06-28 |
2006-01-26 |
Nektar Therapeutics |
Aerosolizable formulation comprising nicotine
|
|
EP1806147B1
(en)
|
2004-10-21 |
2014-04-30 |
Ono Pharmaceutical Co., Ltd. |
Use of immunesuppressant receptor
|
|
ES2331619T3
(es)
*
|
2004-11-24 |
2010-01-11 |
Alcon, Inc. |
Procedimiento de administracion de spray nasal.
|
|
US8563581B2
(en)
|
2005-02-02 |
2013-10-22 |
Mitos Pharmaceuticals, Inc. |
Nitroxides for use in treating predisposed or at risk patients
|
|
US8524734B2
(en)
|
2005-05-18 |
2013-09-03 |
Mpex Pharmaceuticals, Inc. |
Aerosolized fluoroquinolones and uses thereof
|
|
DK2594272T3
(en)
|
2005-05-18 |
2018-09-03 |
Horizon Orphan Llc |
Aerosolized fluoroquinolones and their applications
|
|
ES2675228T3
(es)
*
|
2005-06-17 |
2018-07-09 |
Wisconsin Alumni Research Foundation |
Preparaciones tópicas de vasoconstrictores y métodos para proteger a las células durante la quimioterapia y radioterapia del cáncer
|
|
WO2007049771A1
(ja)
|
2005-10-28 |
2007-05-03 |
Ono Pharmaceutical Co., Ltd. |
塩基性基を含有する化合物およびその用途
|
|
WO2007069565A1
(ja)
|
2005-12-12 |
2007-06-21 |
Ono Pharmaceutical Co., Ltd. |
二環式複素環化合物
|
|
EP1961754A4
(en)
|
2005-12-15 |
2009-11-11 |
Ono Pharmaceutical Co |
BICYCLIC HETEROCYCLIC COMPOUND
|
|
US20070286814A1
(en)
*
|
2006-06-12 |
2007-12-13 |
Medispray Laboratories Pvt. Ltd. |
Stable aerosol pharmaceutical formulations
|
|
MX2009008582A
(es)
|
2007-02-11 |
2009-10-30 |
Map Pharmaceuticals Inc |
Metodo para la administracion terapeutica de dihidroergotamina para permitir un rapido alivio de la migraña mientras se minimiza el perfil de efectos secundarios.
|
|
TW200902019A
(en)
|
2007-04-26 |
2009-01-16 |
Ono Pharmaceutical Co |
Dicyclic heterocyclic compound
|
|
DE102008007198A1
(de)
|
2008-02-01 |
2009-08-13 |
Infectopharm Arzneimittel Und Consilium Gmbh |
Oral oder nasal applizierbare Epinephrin- haltige Zubereitungen mit verbesserten Eigenschaften
|
|
KR20160150110A
(ko)
|
2008-10-07 |
2016-12-28 |
랩터 파마슈티컬스 인코포레이티드 |
약동학 개선을 위한 에어로졸 플루오로퀴놀론 제형
|
|
US8629139B2
(en)
*
|
2008-10-07 |
2014-01-14 |
Mpex Pharmaceuticals, Inc. |
Topical use of Levofloxacin for reducing lung inflammation
|
|
TWI469965B
(zh)
|
2008-12-22 |
2015-01-21 |
Ono Pharmaceutical Co |
乙炔基吲哚化合物
|
|
ES2511065T3
(es)
|
2009-06-17 |
2014-10-22 |
Ono Pharmaceutical Co., Ltd. |
Nuevo compuesto imidazopiridina
|
|
WO2010151804A1
(en)
*
|
2009-06-26 |
2010-12-29 |
Map Pharmaceuticals, Inc. |
Administration of dihydroergotamine mesylate particles using a metered dose inhaler
|
|
LT2473170T
(lt)
|
2009-09-04 |
2019-10-10 |
Horizon Orphan Llc |
Aerozolizuoto levofloksacino panaudojimas cistinės fibrozės gydymui
|
|
WO2011066537A1
(en)
|
2009-11-30 |
2011-06-03 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Nitroxide therapy for the treatment of von hippel - lindau disease (vhl) and renal clear cell carcinoma (rcc)
|
|
US8598223B2
(en)
|
2010-06-21 |
2013-12-03 |
Ono Pharmaceutical Co., Ltd. |
Crystalline forms of 4, 4′-[4-fluoro-7-({4-[4-(3-fluoro-2-methylphenyl) butoxy] phenyl} ethynyl)-2-methyl-1H-indole-1,3-diyl] dibutanoic acid, 4,4′-[2-methyl-7-({4-[4-(pentafluorophenyl) butoxy] phenyl} ethynyl)-1H-indole-1, 3-diyl] dibutanoic acid, and 4,4′-[4-fluoro-2-methyl-7-({4-[4-(2, 3, 4, 6-tetrafluorophenyl) butoxy] phenyl} ethynyl)-1H-indole-1, 3-diyl] dibutanoic acid
|
|
TWI534125B
(zh)
|
2010-12-02 |
2016-05-21 |
Ono Pharmaceutical Co |
Novel compounds, salts thereof or solvates thereof, and pharmaceutical compositions and pharmaceutical products containing the same
|
|
WO2012106382A1
(en)
|
2011-01-31 |
2012-08-09 |
Genoa Pharmaceuticals, Inc. |
Aerosol pirfenidone and pyridone analog compounds and uses thereof
|
|
US9353113B2
(en)
|
2011-03-18 |
2016-05-31 |
Ono Pharmaceutical Co., Ltd. |
Tetrahydrocarboline derivative
|
|
JP6160613B2
(ja)
|
2012-04-26 |
2017-07-12 |
小野薬品工業株式会社 |
Trk阻害化合物
|
|
MX353336B
(es)
|
2013-02-19 |
2018-01-09 |
Ono Pharmaceutical Co |
Compuesto inhibidor de cinasa del receptor de tropomiosina (trk).
|
|
US20150044288A1
(en)
|
2013-07-31 |
2015-02-12 |
Windward Pharma, Inc. |
Aerosol tyrosine kinase inhibitor compounds and uses thereof
|
|
NZ722927A
(en)
|
2014-01-10 |
2022-07-29 |
Avalyn Pharma Inc |
Aerosol pirfenidone and pyridone analog compounds and uses thereof
|
|
US10016439B2
(en)
|
2014-01-31 |
2018-07-10 |
Ono Pharmaceutical Co., Ltd. |
Fused imidazole compounds
|
|
EP3549957A4
(en)
|
2016-11-30 |
2020-08-05 |
Sumitomo Dainippon Pharma Co., Ltd. |
AUXILIARY PEPTIDE WT1, AND COMBINATION OF DUDIT PEPTIDE AND CONJUGATE PEPTIDE ANTIGENIC FOR CANCER
|
|
EP3604325A4
(en)
|
2017-03-30 |
2021-01-13 |
Sumitomo Dainippon Pharma Co., Ltd. |
WT1 CANCER ANTIGEN PEPTIDE AND PEPTIDE CONJUGATE BODY WITH IT
|
|
US20210000830A1
(en)
|
2017-09-06 |
2021-01-07 |
Ono Pharmaceutical Co., Ltd. |
CANCER TREATMENT METHOD USING Trk INHIBITOR AND KINASE INHIBITOR IN COMBINATION
|
|
WO2019230919A1
(ja)
|
2018-05-31 |
2019-12-05 |
小野薬品工業株式会社 |
免疫チェックポイント阻害薬の有効性判定バイオマーカー
|
|
TW202446772A
(zh)
|
2018-10-11 |
2024-12-01 |
日商小野藥品工業股份有限公司 |
Sting促效化合物
|
|
JP7662156B2
(ja)
|
2019-08-05 |
2025-04-15 |
小野薬品工業株式会社 |
免疫チェックポイント阻害薬の有効性判定バイオマーカー
|
|
TW202134213A
(zh)
|
2019-11-29 |
2021-09-16 |
日商小野藥品工業股份有限公司 |
具有水解磷脂酸受體作動活性之化合物及其醫藥用途
|
|
WO2021159077A1
(en)
|
2020-02-07 |
2021-08-12 |
Case Western Reserve University |
Compositions and methods for attenuating opioid induced cardio and/or respiratory depression
|
|
JPWO2021205631A1
(en:Method)
|
2020-04-10 |
2021-10-14 |
|
|
|
CA3182959A1
(en)
|
2020-05-12 |
2021-11-18 |
Sumitomo Pharma Co., Ltd. |
Pharmaceutical composition for treating cancer
|
|
WO2022240897A1
(en)
|
2021-05-10 |
2022-11-17 |
Sepelo Therapeutics, Llc |
Pharmaceutical composition comprising delafloxacin for administration into the lung
|
|
WO2022251679A1
(en)
|
2021-05-27 |
2022-12-01 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Nitroxide radicals for use as antiviral treatment for coronavirus infection
|
|
WO2023028364A1
(en)
|
2021-08-27 |
2023-03-02 |
Sepelo Therapeutics, Llc |
Targeted compositions and uses therof
|